USANA Health Sciences (NYSE:USNA) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of USANA Health Sciences (NYSE:USNA) from a hold rating to a buy rating in a report issued on Saturday.

A number of other research analysts have also recently weighed in on the stock. Zacks Research upgraded shares of USANA Health Sciences from a “strong sell” rating to a “hold” rating in a research note on Monday, February 16th. Weiss Ratings reissued a “sell (d)” rating on shares of USANA Health Sciences in a report on Monday, December 29th. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of $36.00.

USANA Health Sciences Trading Up 0.3%

USNA stock opened at $21.73 on Friday. The stock has a market cap of $397.22 million, a P/E ratio of 39.51, a P/E/G ratio of 0.90 and a beta of 0.67. The stock’s fifty day simple moving average is $20.73 and its two-hundred day simple moving average is $23.40. USANA Health Sciences has a 1-year low of $18.48 and a 1-year high of $38.32.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, February 17th. The company reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.19. The company had revenue of $226.20 million for the quarter, compared to analysts’ expectations of $225.96 million. USANA Health Sciences had a return on equity of 6.75% and a net margin of 1.16%. As a group, analysts forecast that USANA Health Sciences will post 2.45 earnings per share for the current fiscal year.

Insider Buying and Selling at USANA Health Sciences

In related news, insider Joshua Foukas sold 4,461 shares of the business’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $21.34, for a total transaction of $95,197.74. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.63% of the company’s stock.

Institutional Investors Weigh In On USANA Health Sciences

Several large investors have recently added to or reduced their stakes in USNA. State of Tennessee Department of Treasury increased its stake in USANA Health Sciences by 307.8% in the 4th quarter. State of Tennessee Department of Treasury now owns 29,290 shares of the company’s stock worth $636,000 after acquiring an additional 22,108 shares during the last quarter. Empowered Funds LLC grew its holdings in shares of USANA Health Sciences by 10.6% during the fourth quarter. Empowered Funds LLC now owns 60,437 shares of the company’s stock worth $1,186,000 after purchasing an additional 5,782 shares in the last quarter. Tudor Investment Corp ET AL increased its position in shares of USANA Health Sciences by 354.8% in the fourth quarter. Tudor Investment Corp ET AL now owns 109,686 shares of the company’s stock worth $2,153,000 after purchasing an additional 85,570 shares during the last quarter. Numerai GP LLC purchased a new stake in USANA Health Sciences in the fourth quarter valued at approximately $1,027,000. Finally, Millennium Management LLC raised its stake in USANA Health Sciences by 715.7% in the fourth quarter. Millennium Management LLC now owns 285,416 shares of the company’s stock valued at $5,603,000 after purchasing an additional 250,424 shares in the last quarter. Institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.